Phase 3 Trial of GammaTile vs Standard Care in GBM Surgery Initiated
A Phase 3 trial is underway comparing GammaTile implantation with standard care in patients undergoing GBM excision.
Asset / Drug
Drug and asset intelligence for Novocure with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.